Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptide
-
- Target See all ABRA products
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QWADEHIQSQ KLNPFSEEFD YELAMSTRLH KGDEGYGRPK EGTKTAERAK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ABRA Antibody(ARP52674_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Synonyms
- STARS Peptide, C130068O12Rik Peptide, Ms1 Peptide, Stars Peptide, actin binding Rho activating protein Peptide, actin-binding Rho activating protein Peptide, ABRA Peptide, Abra Peptide
- Background
-
ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling.
Alias Symbols: STARS
Protein Interaction Partner: ACTB,ACTC1
Protein Size: 381 - Molecular Weight
- 43 kDa
- Gene ID
- 137735
- NCBI Accession
- NM_139166, NP_631905
- UniProt
- Q8N0Z2
-